CXCR4 and neoplasm: Highly selective small molecule CXCR4 antagonist suppresses tumor growth and prevents distant metastasis and TAMs infiltration in HCC [28], while the canonical CXCR4 inhibitor, AMD3100, reduces MDSCs-mediated murine HCC cell migration to the spleen and liver [52].